SCHEMBL4018178

SCHEMBL4018178

CCCC(=O)[C@@H](Cc1ccc(-c2ccccc2)c(C#N)c1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.42
CYP19A1 P11511 1/20 0.42
MME P08473 3/20 0.40
XDH P47989 2/20 0.40
ITGB1 P05556 1/20 0.40
ITGA4 P13612 1/20 0.40
FFAR4 Q5NUL3 1/20 0.39
GRM5 P41594 1/20 0.39
PTPN1 P18031 1/20 0.39
DGAT1 O75907 1/20 0.39
WNT3A P56704 1/20 0.38
FFAR1 O14842 1/20 0.38
AKR1B1 P15121 1/20 0.38
MRE11 P49959 1/20 0.38
KMT2A Q03164 1/20 0.37
GRIA2 P42262 1/20 0.36
GRIA4 P48058 1/20 0.36
ACE P12821 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4018176 1.00 SLC22A12 (0.42) SLC22A12CYP19A1MMEXDHITGB1
SCHEMBL4448448 0.93 CYP19A1 (0.41) SLC22A12CYP19A1MMEXDHITGB1
SCHEMBL9448762 0.90 MMP8 (0.41) CYP19A1MMEXDHFFAR4GRM5
SCHEMBL8317308 0.87 MME (0.54) MMEITGB1ITGA4PTPN1FFAR1
SCHEMBL27792670 0.82 MMP8 (0.46) CYP19A1XDHGRM5DGAT1WNT3A
SCHEMBL8316083 0.81 MME (0.53) MMEITGB1ITGA4PTPN1FFAR1
SCHEMBL2572010 0.80 MME (0.52) MMEITGB1ITGA4PTPN1FFAR1
SCHEMBL9710320 0.79 MME (0.51) MMEITGB1ITGA4PTPN1FFAR1
SCHEMBL9710577 0.78 MME (0.50) MMEITGB1ITGA4PTPN1FFAR1
SCHEMBL9710219 0.78 MME (0.50) MMEITGB1ITGA4PTPN1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009133970-A1 CRYSTALLINE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-05 WO disclosed
EP-2074117-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-07-01 EP disclosed
WO-2008062905-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-29 WO disclosed